Müller, M., Jeganathan, S., Heidrich, A., Campos, J., & Goody, R. S. (2017). Nucleotide based covalent inhibitors of KRas can only be efficient in vivo if they bind reversibly with GTP-like affinity. Scientific Reports, 7: 3687, pp. 1-11. doi:10.1038/s41598-017-03973-6.